XML 49 R35.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation and Employee Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2021
Stock-Based Compensation Expense
Stock-based compensation expense for the years ended December 31 was as follows (in thousands):
 
    
2021
    
2020
    
2019
 
Cost of revenues
   $ 1,000      $ 934      $ 342  
Selling, general and administrative
     3,873        3,164        1,979  
Research and development
     2,162        1,785        715  
    
 
 
    
 
 
    
 
 
 
Total stock-based compensation
   $ 7,035      $ 5,883      $ 3,036  
    
 
 
    
 
 
    
 
 
 
Summary of Compensation Expense by Type of Award
The increase in stock option compensation expense in 2021 compared to 2020, was primarily due to an increase in the number of stock options granted and higher stock-based compensation expense associated with June 2021 stock option awards.
Compensation expense by type of award for the years ended December 31 was as follows (in thousands):
    
2021
    
2020
    
2019
 
Stock options
   $ 6,122      $ 4,982      $ 2,072  
ESPP
     913        901        964  
    
 
 
    
 
 
    
 
 
 
Total stock-based compensation
   $ 7,035      $ 5,883      $ 3,036  
    
 
 
    
 
 
    
 
 
 
Weighted-Average Assumptions for Non Performance-Based Fair Value for Stock Options
The fair value for
non-performance-based
stock options awarded under the 2000 Plan for the years shown below was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions:
 
    
2021
   
2020
   
2019
 
Risk-free interest rate
     0.8     0.5     1.8
Expected dividend yield
                  
Expected volatility
     49     48     42
Expected lives (years)
     4.9       6.1       6.3  
2000 Plan, Vicor [Member]  
Stock-Based Compensation Expense
A summary
 of the activity under the 2000 Plan as of December 31, 2021 and changes during the year then ended, is presented below (in thousands except for share and weighted-average data):
 
    
Options
Outstanding
   
Weighted-
Average
Exercise
Price
    
Weighted-
Average
Remaining
Contractual
Life in
Years
    
Aggregate
Intrinsic
Value
 
Outstanding on December 31, 2020
     2,023,477     $ 20.98                    
Granted
     267,559     $ 93.40                    
Forfeited and expired
     (61,924   $ 58.95                    
Exercised
     (551,451   $ 13.81                    
    
 
 
                           
Outstanding on December 31, 2021
     1,677,661     $ 33.48        4.56      $ 157,309  
    
 
 
                           
Exercisable on December 31, 2021
     776,559     $ 11.63        2.93      $ 89,576  
    
 
 
                           
Vested or expected to vest as of December 31, 2021(1)
     1,617,003     $ 32.10        4.46      $ 153,817  
    
 
 
                           
 
(1)
In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. The number of options expected to vest is calculated by applying an estimated forfeiture rate to the unvested options.